Medical Equipment

Rising Cancer Incidence Fueling Growth in the Closed System Transfer Devices Market Is Supporting Development Across The Closed System Transfer Devices Market

May 12, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Size Of The Closed System Transfer Devices Market Progress Through 2030?

The closed system transfer devices market has expanded quickly over recent years. Its value is anticipated to rise from $1.18 billion in 2025 to $1.35 billion in 2026, at a compound annual growth rate (CAGR) of 14.2%. Historically, this growth has been driven by the increasing application of hazardous drugs in oncology, greater awareness of occupational exposure risks, the implementation of safety guidelines for drug handling, the expansion of hospital oncology services, and the growing adoption of chemotherapy infusion therapies.

The market for closed system transfer devices is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $2.18 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. Factors driving this growth during the forecast period include more stringent regulatory enforcement concerning the handling of hazardous drugs, an increase in cancer treatment volumes, a heightened focus on adherence to workplace safety, the global expansion of oncology centers, and increased financial commitments to hospital pharmacy safety infrastructure. Key trends observed within this period encompass the growing integration of closed drug handling systems within oncology, an intensified concentration on safeguarding healthcare workers and minimizing their exposure, a surging preference for needleless closed transfer systems, the broader implementation of CSTD across hospital pharmacies, and an enhanced standardization of protocols for handling hazardous drugs.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

Which Growth Drivers Are Expected To Support The Closed System Transfer Devices Market Forward?

The rising incidence of cancer is anticipated to fuel the expansion of the closed-system transfer devices market in the future. This illness involves the unchecked multiplication of abnormal cells, which are capable of infiltrating adjacent tissues and migrating to other areas of the body via the bloodstream and lymphatic systems. The growing number of cancer cases stems from multiple contributors, including lifestyle choices, environmental influences, and heightened infection rates. In cancer therapy, closed-system transfer devices serve as crucial instruments, safeguarding both healthcare professionals and patients from hazards linked to the handling and delivery of chemotherapy medications. These devices foster a more secure healthcare setting and lead to improved treatment results for individuals with cancer. For example, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported in February 2024 that cancer cases are projected to surpass 35 million by 2050, marking a 77% surge from the approximately 20 million cases estimated for 2022. This considerable increase underscores the escalating global impact of cancer. Additionally, the National Center for Biotechnology Information, a US-based intergovernmental organization, stated in January 2023 that the United States anticipated 1,958,310 new cancer cases and 609,820 cancer deaths in 2023. Consequently, the escalating number of cancer cases acts as a key driver for the closed system transfer devices market.

What Segment Categories Are Evaluated In The Closed System Transfer Devices Market Study?

The closed system transfer devices market covered in this report is segmented –

1) By Type: Needleless Systems, Membrane-To-Membrane Systems

2) By Technology: Diaphragm-Based, Compartmentalized, Filtration

3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems

4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

Subsegments:

1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters

2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

What Trends Are Shaping The Closed System Transfer Devices Market Structure?

Leading companies in the closed system transfer devices (CSTD) market are concentrating on developing advanced syringe units to boost safety, improve user experience, decrease contamination risks, and meet strict regulatory standards within the healthcare sector. A syringe unit for full volume use signifies a syringe engineered to dispense or administer the entire quantity of liquid or medication it holds, without requiring additional mixing or dilution. For example, in October 2023, Equashield, a US-based medical device company, introduced the EQUASHIELD Syringe Unit, which has secured FDA clearance for full-volume use, facilitating safer and more efficient handling of hazardous drugs. This innovative design prevents vapor escape and plunger contamination, positioning it as an economical solution for compounding and administering medications.

Which Organizations Are Involved In The Closed System Transfer Devices Market?

Major companies operating in the closed system transfer devices market are Cardinal Health Inc., Becton Dickinson and Company, Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Aegis Medical Technologies, Epic Medical Pte Ltd., Smiths Medical

Access The Complete Closed System Transfer Devices Market Report:

https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

Which Regional Market Leads The Closed System Transfer Devices Market?

North America was the largest region in the closed system transfer device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Closed System Transfer Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp

Browse Through More Reports Similar to the Global Closed System Transfer Devices Market 2026, By The Business Research Company

White Biotechnology Market Report 2026

https://www.thebusinessresearchcompany.com/report/white-biotechnology-global-market-report

Pet Cloning Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-cloning-global-market-report

Synthetic Biology Market Report 2026

https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795